Manufacturer record

Oushadhi: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Oushadhi (Kerala) was declared Not of Standard Quality in September 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: P 592324, Yogaraja Guggulu Tablet (exp Sep 2026). DTL Thiruvananthapuram (state lab) found it not of standard quality: The sample does not conform to API Standards. It fails the tests ?Total Ash? as per API Standards. Listed in the September 2024 alert.

Records by type

1 record linked to Oushadhi in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2024 to Sep 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2024
1
Products affected
Other
Most common failure
Sep 2024
Latest alert

Flagged batches per year

2024 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Yogaraja Guggulu Tablet Batch P 592324Mfg Oct 2023 · Exp Sep 2026 The sample does not conform to API Standards. It fails the tests ?Total Ash? as per API Standards.Other DTL ThiruvananthapuramState lab Sep 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.